Published in Nat Biotechnol on November 01, 2001
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Complexity in biomaterials for tissue engineering. Nat Mater (2009) 4.38
Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest (2004) 3.53
Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation (2005) 2.89
Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A (2003) 2.86
Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci U S A (2006) 2.82
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Engineering complex tissues. Tissue Eng (2006) 2.53
Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A (2009) 2.48
Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett (2010) 2.35
Vascularization strategies for tissue engineering. Tissue Eng Part B Rev (2009) 2.31
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A (2009) 2.29
Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng (2012) 2.27
Inspiration and application in the evolution of biomaterials. Nature (2009) 2.23
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone (2008) 2.19
Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A (2009) 2.14
Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A (2009) 2.07
Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A (2010) 2.06
Infection-mimicking materials to program dendritic cells in situ. Nat Mater (2009) 2.00
The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering. J Endod (2008) 1.95
Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics. Adv Drug Deliv Rev (2008) 1.74
Microfabricated biomaterials for engineering 3D tissues. Adv Mater (2012) 1.65
Custom design of the cardiac microenvironment with biomaterials. Circ Res (2005) 1.63
Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther (2005) 1.62
Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev (2012) 1.57
Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol (2008) 1.56
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J Clin Invest (2005) 1.55
Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther (2008) 1.53
A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo. Proc Natl Acad Sci U S A (2006) 1.52
Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials (2009) 1.50
Three-Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible Biodegradable Polymer. Adv Mater (2005) 1.49
Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev (2007) 1.47
In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia. Int J Nanomedicine (2013) 1.47
Microporous dermal-mimetic electrospun scaffolds pre-seeded with fibroblasts promote tissue regeneration in full-thickness skin wounds. PLoS One (2015) 1.41
Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release (2006) 1.40
Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A (2006) 1.39
Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther (2010) 1.39
Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog (2009) 1.36
Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J Biomed Mater Res A (2007) 1.35
Homogeneous and organized differentiation within embryoid bodies induced by microsphere-mediated delivery of small molecules. Biomaterials (2009) 1.34
Geometrically controlled endothelial tubulogenesis in micropatterned gels. Tissue Eng Part A (2010) 1.33
Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater (2010) 1.33
Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr (2008) 1.32
Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials (2009) 1.32
Enabling stem cell therapies through synthetic stem cell-niche engineering. J Clin Invest (2010) 1.31
Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med (2014) 1.27
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One (2008) 1.26
Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials. Curr Top Med Chem (2008) 1.25
Macroscale delivery systems for molecular and cellular payloads. Nat Mater (2013) 1.25
Biomimetic delivery with micro- and nanoparticles. Adv Mater (2012) 1.25
Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng Part B Rev (2012) 1.24
Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering. Tissue Eng Part B Rev (2008) 1.24
The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials (2007) 1.24
Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. J Control Release (2008) 1.23
Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation (2006) 1.23
Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials (2011) 1.23
Silk Fibroin Microfluidic Devices. Adv Mater (2007) 1.21
Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol (2007) 1.20
Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels. Biomacromolecules (2006) 1.20
Geometric control of vascular networks to enhance engineered tissue integration and function. Proc Natl Acad Sci U S A (2013) 1.19
Update on therapeutic vascularization strategies. Regen Med (2009) 1.17
Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. Am J Pathol (2007) 1.17
The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. Biomaterials (2010) 1.16
Cementum engineering with three-dimensional polymer scaffolds. J Biomed Mater Res A (2003) 1.16
Self-folding devices and materials for biomedical applications. Trends Biotechnol (2011) 1.16
Engineering Stem Cell Organoids. Cell Stem Cell (2016) 1.15
Accelerated wound healing by injectable microporous gel scaffolds assembled from annealed building blocks. Nat Mater (2015) 1.14
Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials (2013) 1.14
Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite/poly(lactide-co-glycolide) composite scaffolds. Tissue Eng Part A (2010) 1.13
Pulp and dentin tissue engineering and regeneration: current progress. Regen Med (2009) 1.13
Tissue engineering tools for modulation of the immune response. Biotechniques (2011) 1.12
Photodegradable macromers and hydrogels for live cell encapsulation and release. J Am Chem Soc (2012) 1.12
Tumor engineering: the other face of tissue engineering. Tissue Eng Part A (2010) 1.12
Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J (2008) 1.11
Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small (2008) 1.11
Multifunctional hydrogels that promote osteogenic hMSC differentiation through stimulation and sequestering of BMP2. Adv Funct Mater (2007) 1.10
Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev (2007) 1.10
Tissue engineering: state of the art in oral rehabilitation. J Oral Rehabil (2009) 1.10
The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials (2011) 1.09
Gene therapeutics for periodontal regenerative medicine. Dent Clin North Am (2006) 1.09
Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng (2006) 1.09
Self-folding polymeric containers for encapsulation and delivery of drugs. Adv Drug Deliv Rev (2012) 1.09
Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation. Acta Biomater (2012) 1.09
A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications. AAPS PharmSci (2003) 1.09
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. Biomaterials (2008) 1.08
Visualizing light-triggered release of molecules inside living cells. Nano Lett (2010) 1.07
Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev (2012) 1.07
Protein-engineered biomaterials: nanoscale mimics of the extracellular matrix. Biochim Biophys Acta (2010) 1.07
Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm Res (2009) 1.07
Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits. Tissue Eng (2007) 1.07
Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. Biomaterials (2014) 1.06
MAD (multiagent delivery) nanolayer: delivering multiple therapeutics from hierarchically assembled surface coatings. Langmuir (2009) 1.06
Mesenchymal stem cells for vascular regeneration. Regen Med (2008) 1.06
Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J Surg Res (2009) 1.06
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacol Ther (2016) 1.06
Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng Part A (2009) 1.05
Stromal cell identity influences the in vivo functionality of engineered capillary networks formed by co-delivery of endothelial cells and stromal cells. Tissue Eng Part A (2013) 1.05
Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta Biomater (2012) 1.05
Acellular biomaterials: an evolving alternative to cell-based therapies. Sci Transl Med (2013) 1.05
Hydrogels for tissue engineering. Chem Rev (2001) 7.25
Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials (1999) 4.69
DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol (1999) 3.37
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol (1999) 3.15
Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest (2001) 2.61
Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res (1998) 2.22
Controlled growth factor release from synthetic extracellular matrices. Nature (2001) 2.15
Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol (1998) 2.01
Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res (2001) 1.95
Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol (1999) 1.94
Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost (2007) 1.92
Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res (2001) 1.92
Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog (2001) 1.91
Regulating bone formation via controlled scaffold degradation. J Dent Res (2003) 1.72
Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell (1994) 1.61
Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials (2000) 1.52
Injection molding of chondrocyte/alginate constructs in the shape of facial implants. J Biomed Mater Res (2001) 1.42
Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res (2000) 1.42
Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release (2000) 1.36
Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther (2005) 1.35
Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro. J Biomed Mater Res (2000) 1.35
Control of microtubule assembly by extracellular matrix and externally applied strain. Am J Physiol Cell Physiol (2001) 1.25
Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res (2004) 1.25
Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng (2000) 1.23
Release from alginate enhances the biological activity of vascular endothelial growth factor. J Biomater Sci Polym Ed (1998) 1.20
Decrease in inflammatory hyperalgesia by herpes vector-mediated knockdown of Nav1.7 sodium channels in primary afferents. Hum Gene Ther (2005) 1.20
Optimizing seeding and culture methods to engineer smooth muscle tissue on biodegradable polymer matrices. Biotechnol Bioeng (1998) 1.19
Transplanted endothelial cells enhance orthotopic bone regeneration. J Dent Res (2006) 1.18
Welding arc maculopathy and fluphenazine. Br J Ophthalmol (1991) 1.17
Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart (2007) 1.17
Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. Exp Cell Res (1999) 1.16
Tissue engineering using synthetic extracellular matrices. Nat Med (1996) 1.11
Scaffolds for engineering smooth muscle under cyclic mechanical strain conditions. J Biomech Eng (2000) 1.11
Craniofacial tissue engineering. Crit Rev Oral Biol Med (2001) 1.11
Aging affects two modes of nanoleakage expression in bonded dentin. J Dent Res (2003) 1.10
Combining chondrocytes and smooth muscle cells to engineer hybrid soft tissue constructs. Tissue Eng (2000) 1.09
Dynamic seeding and in vitro culture of hepatocytes in a flow perfusion system. Tissue Eng (2000) 1.05
Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials (2000) 1.03
Microtubule assembly is regulated by externally applied strain in cultured smooth muscle cells. J Cell Sci (1998) 1.02
Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J Periodontal Res (1999) 1.02
Comparative study of seeding methods for three-dimensional polymeric scaffolds. J Biomed Mater Res (2000) 1.00
Smooth muscle cell adhesion to tissue engineering scaffolds. Biomaterials (2000) 1.00
Hydrogels for combination delivery of antineoplastic agents. Biomaterials (2001) 0.97
Role of synthetic extracellular matrix in development of engineered dental pulp. J Biomater Sci Polym Ed (1998) 0.97
Curing light performance and polymerization of composite restorative materials. J Dent (1992) 0.96
Highly porous polymer matrices as a three-dimensional culture system for hepatocytes. Cell Transplant (1997) 0.95
High-resolution elasticity imaging for tissue engineering. IEEE Trans Ultrason Ferroelectr Freq Control (2000) 0.95
Degradable and injectable poly(aldehyde guluronate) hydrogels for bone tissue engineering. J Biomed Mater Res (2001) 0.94
Biodegradable external tracheal stents and their use in a rabbit tracheal reconstruction model. Laryngoscope (2000) 0.92
Stress analysis of a tooth restored with a post and core. J Dent Res (1983) 0.92
Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia. Pain (2004) 0.91
Development of technologies aiding large-tissue engineering. Biotechnol Prog (1998) 0.91
The growth and morphological behavior of salivary epithelial cells on matrix protein-coated biodegradable substrata. Tissue Eng (2000) 0.90
Retinal function in Stargardt's disease and fundus flavimaculatus. Am J Ophthalmol (1983) 0.90
Sustained and controlled release of daunomycin from cross-linked poly(aldehyde guluronate) hydrogels. J Pharm Sci (2000) 0.90
Engineering smooth muscle tissue with a predefined structure. J Biomed Mater Res (1998) 0.90
Regenerative signals for tissue-engineered small intestine. Transplant Proc (1999) 0.89
Promoting angiogenesis in engineered tissues. J Drug Target (2001) 0.87
Effects of polymerization contraction in composite restorations. J Dent (1992) 0.86
Angioid streaks in beta thalassaemia minor. Br J Ophthalmol (1988) 0.86
A study of glass-ionomer cement and its interface with enamel and dentin using a low-temperature, high-resolution scanning electron microscopic technique. Quintessence Int (1997) 0.85
The impact of tissue engineering on dentistry. J Am Dent Assoc (2000) 0.85
Re-engineering the functions of a terminally differentiated epithelial cell in vivo. Ann N Y Acad Sci (1999) 0.85
Enterocyte transplantation using cell-polymer devices to create intestinal epithelial-lined tubes. Transplant Proc (1993) 0.84
Tissue compatibility of two biodegradable tubular scaffolds implanted adjacent to skin or buccal mucosa in mice. Tissue Eng (2002) 0.84
Survival and function of rat hepatocytes cocultured with nonparenchymal cells or sinusoidal endothelial cells on biodegradable polymers under flow conditions. J Pediatr Surg (2000) 0.83
The influence of modification of cavity design on distribution of stresses in a restored molar. J Dent Res (1984) 0.83
Integrin organization: linking adhesion ligand nanopatterns with altered cell responses. J Theor Biol (2011) 0.83
Tissue engineering lamb heart valve leaflets. Biotechnol Bioeng (1996) 0.83
In vivo dentin microhardness beneath a calcium-phosphate cement. J Dent Res (2010) 0.82
The strength of auto-cured and light-cured materials. The shear punch test. Aust Dent J (1996) 0.82
Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit Rev Eukaryot Gene Expr (2001) 0.82
Regenerative signals for intestinal epithelial organoid units transplanted on biodegradable polymer scaffolds for tissue engineering of small intestine. Transplantation (1999) 0.82
Anaphylaxis following oral fluorescein angiography. Am J Ophthalmol (1988) 0.82
End-to-end anastomosis between tissue-engineered intestine and native small bowel. Tissue Eng (1999) 0.81
Electron probe microanalysis and transverse microradiography studies of artificial lesions in enamel and dentin: a comparative study. Adv Dent Res (1997) 0.81
Cellular ingrowth and thickness changes in poly-L-lactide and polyglycolide matrices implanted subcutaneously in the rat. J Biomed Mater Res (1998) 0.81
Effects of anastomosis of tissue-engineered neointestine to native small bowel. J Surg Res (1999) 0.81
Failure stress criteria for composite resin. J Dent Res (1987) 0.80
Verification of theoretical modeling of heat transmission in teeth by in vivo experiments. J Dent Res (1987) 0.80
At the edge of translation - materials to program cells for directed differentiation. Oral Dis (2010) 0.80
Fatigue behavior of direct post-and-core-restored premolars. J Dent Res (1992) 0.80
Enamel cracks. The role of enamel lamellae in caries initiation. Aust Dent J (1998) 0.80
Using HSV-thymidine kinase for safety in an allogeneic salivary graft cell line. Tissue Eng (2001) 0.80
Effect of bur type and conditioning on the surface and interface of dentine. J Oral Rehabil (2005) 0.80
The pattern ERG in Best's disease. Doc Ophthalmol (1991) 0.79
Use of internal bioabsorbable PLGA "finger-type" stents in a rabbit tracheal reconstruction model. Arch Otolaryngol Head Neck Surg (2000) 0.79
Transplantation of enterocytes utilizing polymer-cell constructs to produce a neointestine. Transplant Proc (1992) 0.79
Small intestinal submucosa as a small-caliber venous graft: a novel model for hepatocyte transplantation on synthetic biodegradable polymer scaffolds with direct access to the portal venous system. J Pediatr Surg (1999) 0.78
The influence of restorative dental materials on heat transmission in human teeth. J Dent Res (1984) 0.78
Highly porous polymer matrices as a three-dimensional culture system for hepatocytes: initial results. Transplant Proc (1997) 0.77
Surface temperature of oral tissues. A review. J Biol Buccale (1984) 0.77
Transit of micro-bubbles through the pulmonary circulation of Thoroughbred horses during exercise. Res Vet Sci (2013) 0.76
Fracture mechanics parameters for failure prediction of composite resins. J Dent Res (1988) 0.75
In vivo acid etching effect on bacteria within caries-affected dentin. Caries Res (2010) 0.75